PRI Insider (Volume 4, Issue 17) May 3
In This Issue: The Center for Disease Control and Prevention has released the provisional birth rate data for 2023 and the U.S. was once again in decline. The statistics revealed that a little under 3.6 million babies were born last year, which is 76,000 fewer than the year before. It is also the lowest one-year tally since 1979.
PRI Insider (Volume 4, Issue 17) April 26
In This Issue: In March, Iowa tabled legislation that would have made it a felony to “cause the death” of an “unborn person.” Iowa is trying to avoid introducing personhood legislation, which recognizes the unborn child as having legal rights and protections. Alabama’s recent Supreme Court decision regarding IVF put personhood legislation in the spotlight for all the states.
PRI Insider (Volume 4, Issue 15) April 19th
In This Issue: Planned Parenthood’s 2022-2023 annual report revealed that the organization provided a total of 392,715 abortions. If the CDC factored child deaths caused by abortion into their “Leading Causes of Death” data, that would make Planned Parenthood-performed abortions the fourth leading cause of death, behind heart disease, cancer, and Covid-19.
PRI Insider (Volume 4, Issue 14) April 12
In This Issue: New data regarding American fertility may hold a silver lining to the “birth dearth” that the nation is experiencing. As we have highlighted previously, the U.S. fertility rate is below replacement and, in general, continues to trend downward. However, data from 2022 suggests that while Americans are having fewer babies, the babies that are being born are more likely to be born to married parents.
PRI Insider (Volume 4, Issue 13) April 5
In This Issue: This week, the political network for values celebrated our Ibero-American office’s 20th anniversary on social media, stating the following:
“Congratulations to the Population Research Institute for their 20 years of service in Ibero-America. We join them in the celebration and look forward to continuing to work together to defend life, family, and liberties.”
PRI Insider (Volume 4, Issue 12) March 29
In This Issue: On March 26th, the Supreme Court began hearing oral arguments for the case that will decide the future of the abortion pill. Since the pandemic, the FDA has loosened restrictions on the abortion drugs mifepristone and misoprostol. According to one expert, “The telehealth policy, which the FDA temporarily implemented during the COVID-19 pandemic before making it permanent, is really ‘what opened the gate’ to the drug’s broader use.” This has directly contributed to the uptick in abortions. Last year, the total number of abortions in the U.S. surpassed 1 million for the first time in over a decade.
